跳至主要内容
临床试验/NCT01979328
NCT01979328已完成早期 1 期

The Efficacy of a Neuromuscular Stimulation Device (Geko™) in Promoting Blood Flow in a Plaster Cast as a Way of Offering Mechanical DVT Prophylaxis

University Hospital Southampton NHS Foundation Trust2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
早期 1 期
状态
已完成
入组人数
10
试验地点
2
主要终点
Blood flow

研究概览

简要总结

The primary objective of this study is to examine the flow characteristics of deep venous flow in the leg veins using Doppler ultrasound imaging and how this flow is modified by the application of a plaster and with a geko™ device in healthy volunteers

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Be in good general health and fitness.
  • Aged between 18 and 65 years.
  • Free of significant abnormal findings as determined by medical history (specifically an absence of DVT or haematological disorders or indications), screening physical examination, vital signs (sitting blood pressure, sitting pulse rate, sitting respiratory rate and body temperature) and duplex ultrasound)
  • BMI between 18 and 34
  • No history or signs of drug abuse (including alcohol), licit or illicit.
  • Has not used any medications (prescribed or over-the-counter including herbal remedies) judged to be significant by the Principal Investigator during the thirty (30) days preceding the study, and agrees not to use any medications during the course of the study without informing the Research Team.
  • Able to understand the Volunteer Information Sheet and signed the written Informed Consent Forms.
  • Able and willing to follow the Protocol requirements.

排除标准

  • Previous leg fracture. (within the last 12 months)
  • Any evidence of organ dysfunction, or any clinically significant deviation from normal in the physical determinations.
  • History or signs of haematological disorders (especially in relation to clotting or coagulation or previous Deep or superficial vein thrombosis/pulmonary embolism) or familiar history of such.
  • Peripheral arterial disease (ABPI<0.9), clinically significant varicose veins or lower limb ulceration.
  • Musculoskeletal disorders (such as pain during exercise of lower limb, rheumatoid or osteoarthritis).
  • Neurological disorders,(such as stroke, multiple sclerosis)
  • Recent surgery (such as abdominal, gynaecological, hip knee replacement).
  • Recent trauma to lower limbs.
  • Chronic Obesity (BMI Index >34).
  • Any Medication judged to be significant by the Principal Investigator.
  • Tobacco consumption
  • History of disorders of the gastrointestinal, hepatic, renal, cardiovascular, endocrine, neurological, dermatological, rheumatologic, metabolic (including diabetes), psychiatric, haematological (especially in relation to clotting or coagulation), or systemic disease judged to be significant.
  • A pulse rate of less than 50 beats/minute, a sitting systolic blood pressure >160 or <80 mmHg and/or a sitting diastolic pressure of >90 or <60 mmHg.
  • Any significant illness during the four (4) weeks preceding the screening period of the study.
  • Any contraindication to blood sampling.
  • Donation of blood during the eight (8) weeks preceding the screening period of the study or during the investigation.
  • Participation in any clinical study during the 8 weeks preceding the dosing period of the study
  • Fitted with a pacemaker or defibrillator

结局指标

主要结局

Blood flow

时间窗: 4 hours

次要结局

  • microcirculatory blood flow(4 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验